Back to Journals » Drug Design, Development and Therapy » Volume 11

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

Total article views   HTML views PDF downloads Totals
11,097 Dovepress* 10,679+ 1,778 12,457
PubMed Central* 418 141 559
Totals 11,097 1,919 13,016
*Since 17 January 2017

View citations on PubMed Central and Google Scholar